Last reviewed · How we verify

NCT06068933: K-HEARS MCI

Hearing Health for Korean American Older Adults With Mild Cognitive Impairment

Terminated NA Last updated 6 April 2025
What this trial tests

NA trial testing K-HEARS Intervention in Age-related Hearing Impairment in 1 participant. Terminated before completion.

Timeline
12 December 2023
Primary endpoint
8 August 2024
27 November 2024

Quick facts

Lead sponsorJohns Hopkins University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment1
Start date12 December 2023
Primary completion8 August 2024
Estimated completion27 November 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins University

Who can join

Adults 60 to 100, any sex, with Age-related Hearing Impairment or Personal Communication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to develop and assess the feasibility, acceptability, and preliminary efficacy of a community-delivered, affordable, and accessible hearing care intervention tailored to the needs of community-dwelling Korean American (KA) older adults with mild cognitive impairment (MCI) and their care partners that integrates a low-cost over-the-counter amplification device and hearing rehabilitation through a randomized controlled pilot study. Each dyad will consist of the study participant and their care partner.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of K-HEARS Intervention

Trials testing the same drug.

Other Johns Hopkins University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06068933.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing